News

Vetter Pharma, has begun the construction of a new clinical manufacturing facility in Des Plaines, Illinois, US.
As the pharma sector braces for sector-specific tariffs from President Trump, what could the impact look like on supply ...
The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, ...
Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.
Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.
I’m in London, and I just paid for this damn fat drug I take. I said, it’s not working. They said, he said, I just paid $88 ...
While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...
Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...
The evolving landscape of vaccine oversight makes it key to maintain public trust and keep scientific integrity at the ...
Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...
The US FDA has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid.